HOME >> BIOLOGY >> NEWS
Hepatitis B drug can compromise HIV treatment

Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal, according to a new report in the New England Journal of Medicine.

In findings published June 21, 2007, online in the journal, the researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine. Entecavir is manufactured by Bristol-Myers Squibb and is marketed under the trade name Baraclude.

The research team was led by Chloe Thio and Howard Hughes Medical Institute investigator Robert Siliciano, both at The Johns Hopkins University School of Medicine. The analyses reported in the paper were performed by lead authors Moira McMahon, Benjamin Jilek, and Timothy Brennan in the Siliciano laboratory.

The groups initial report of the findings in February, 2007, at the Conference on Retroviruses and Opportunistic Infections led the drugs manufacturer, Bristol-Myers Squibb, to change its product labeling to warn of the potential for HIV drug resistance, notify prescribing physicians, and inform the Food and Drug Administration. The United States Department of Health and Human Services now recommends against using entecavir as the first option in treating hepatitis B in co-infected patients who are not already using drugs to suppress HIV. More than 4 million people worldwide are believed to be infected with both viruses.

The scientists emphasized that finding drug resistance in this setting underscores the need to test all antiviral drugs for anti-HIV activity before they are approved for use.

Entecavir is a chemically altered version of a chemical called a nucleoside. The drug blocks viral replication by plugging itself into a polymerase enzyme in the hepatitis B virus that helps produce new viral DNA
'"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
20-Jun-2007


Page: 1 2 3

Related biology news :

1. Hepatitis C helicase unwinds DNA in a spring-loaded, 3-step process
2. Hepatitis E takes a piggyback
3. New hope for Hepatitis C research
4. Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
5. New insights into protein synthesis and Hepatitis C infections
6. Hepatitis B accounts for 40 percent of missing Asian women
7. Hepatitis C complicated by morphine withdrawal
8. Identification of a protein important for Hepatitis B replication
9. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
10. Hepatitis C virus linked to non-Hodgkins lymphoma
11. Group decisions: From compromise to leadership in pigeon homing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... ... July 08, 2019 , ... ... the biotechnology hub of Cambridge, MA. This expansion strengthens KMK’s presence for the ... , and sales force effectiveness consulting for the biotechnology corridor. With ...
(Date:7/5/2019)... ... July 05, 2019 , ... SteriTrack Inc. is ... Platform to governments around the world. , Powered by Microsoft Azure, the ... care solutions to operating theatres worldwide to address new global regulations mandating all ...
(Date:6/25/2019)... ... June 25, 2019 , ... ActX has launched a medical ... from 23andMe, customers can get access to professionally reviewed genetic screening similar to ... Ancestry and Health + Ancestry customers., With the ActX + 23andMe service, both ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... ... May 03, 2019 , ... More ... the Dakila Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, last ... Urandir detailed the results of some research carried out by the association, in ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... REPROCELL USA Inc. has demonstrated its ability to provide various services and ... to enhance customer satisfaction through the effective implementation of its quality management ...
(Date:5/2/2019)... TORONTO (PRWEB) , ... May 02, 2019 , ... Stay ... pharma, biotech, medical device and food industries. Access to all webinars is free, so ... stay relevant in your field! , Visit http://www.xtalks.com to see our upcoming ...
(Date:5/2/2019)... (PRWEB) , ... May 02, 2019 , ... ... transplantation clinic in the greater Boston area. Gone are the days of painful ... ARTAS® iX Robotic Hair Restoration System is the only robotic intelligent solution to ...
Breaking Biology Technology:
Cached News: